Izotropic (IZOZF) AI Stock Analysis

Izotropic

(Other OTC:IZOZF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Defined Product FocusA clearly defined breast-imaging product gives Izotropic a focused path toward commercialization in a specific diagnostic niche. If IzoView gains clinical adoption, its dedicated design could support system sales plus longer-term service, software, maintenance, and support revenue.

Negative Factors

Pre-Revenue OperationsNo reported revenue means Izotropic has not yet established a commercial product base or demonstrated recurring customer demand. Until IzoView generates sales, operating performance depends primarily on funding and continued development rather than internally generated business momentum.

Izotropic (IZOZF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $7.25M
Dividend Yield: ―
Average Volume (3M): 25.64K
Price to Earnings (P/E): -4.1
Beta (1Y): -0.60
Revenue Growth: ―
EPS Growth: 8.92%
Country: US
Employees: 5
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Diagnostics & Research

Izotropic Business Overview & Revenue Model

Company Description

Izotropic Corporation operates as a MedTech enterprise, concentrating on the commercialization of diagnostic solutions for breast cancer. Their primary focus lies in developing and offering a breast CT imaging system alongside a 3D CT breast imaging...

Izotropic Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

IZOZF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:VPT	46Neutral	CAD 15.43M	-6.13	56.40%	―	89.06%	37.62%
TSE:BUX	40Underperform	CAD 50.05M	-34.81	-250.77%	―	-82.05%	23.73%
TSE:EDT	40Underperform	CAD 303.48M	-8.01	51.23%	―	1.46%	-64.85%
TSE:SONA	40Underperform	CAD 34.38M	-13.08	448.05%	―	―	24.65%
TSE:PINK	38Underperform	CAD 27.62M	-1.41	-303.05%	―	35.27%	58.34%

* Healthcare Sector Average

Performance Comparison

IZOZF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IZOZF	Izotropic Corp	0.10	-0.21	-66.77%
TSE:EDT	Spectral Medical (Edtxf)	1.03	-0.44	-29.93%
TSE:BUX	BioMark Diagnostics	0.47	0.13	38.24%
TSE:PINK	Perimeter Medical Imaging Ai Inc	0.18	-0.05	-23.40%
TSE:SONA	Sona Nanotech, Inc	0.28	-0.33	-54.10%
TSE:VPT	VentriPoint Diagnostics	0.08	-0.02	-20.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Izotropic AI Stock Analysis